Brincidofovir (CMX001) for the Treatment of Severe Adenoviral Pneumonia in Kidney Transplant Recipient

Adenovirus causes significant morbidity and mortality in solid organ and hematological transplant recipients. Treatment of adenovirus infections includes supportive care, reduction of immune suppression, and in patients with severe disease, intravenous cidofovir. Brincidofovir (CMX001) is a lipid co...

Descripción completa

Detalles Bibliográficos
Autores principales: Sudhindra, Praveen, Knoll, Bettina, Nog, Rajat, Singh, Nandita, Dhand, Abhay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Infectious Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768614/
https://www.ncbi.nlm.nih.gov/pubmed/31579636
http://dx.doi.org/10.7759/cureus.5296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768614/
https://www.ncbi.nlm.nih.gov/pubmed/31579636
http://dx.doi.org/10.7759/cureus.5296

Ejemplares similares